ABPS Hospital Medicine study materials
ABPS Hospital Medicine study resources

Fever and Hypotension on the Ward: Antibiotics and the Stewardship Question

ABPS Hospital Medicine · Put your knowledge to work in context.

All case studies

Fever and Hypotension on the Ward: Antibiotics and the Stewardship Question

A 63-year-old woman with cirrhosis (MELD 18), type 2 diabetes, and a recent 10-day course of ceftriaxone for a urinary tract infection is admitted with 2 days of fever and confusion. Vitals: T 38.9 C, HR 124, BP 88/54 (MAP 65), RR 26, SpO2 93% on room air. Exam: jaundiced, ascites, diffuse abdominal tenderness without guarding, cool extremities. Labs: WBC 18.4 with 12% bands, platelets 88, creatinine 1.9 (baseline 1.2), lactate 3.4, total bilirubin 3.8, INR 1.7, albumin 2.4. Blood and urine cultures are drawn; a diagnostic paracentesis yields cloudy fluid with PMN 640/mm3, glucose 62, protein 1.1 g/dL, LDH elevated. She has a documented severe penicillin allergy (anaphylaxis).

1. Make the diagnosis and justify it with the ascitic fluid data. What is the single most important management decision in the first hour?

Read the worked answer

Diagnosis: spontaneous bacterial peritonitis (SBP) with septic shock physiology in a patient with cirrhosis.

Ascitic fluid criteria:

  • PMN ≥250/mm3 is diagnostic - here 640/mm3.
  • Low glucose (<50 mg/dL) and high LDH and **protein <1 g/dL** suggest a *secondary* peritonitis (surgical source) or advanced infection; the combination of PMN >250 with low glucose/high LDH warrants consideration of secondary peritonitis (perforation) - obtain imaging and surgical consultation. Culture will guide organism.

Most important first-hour decision: empiric IV antibiotics without delay - every hour of delay in septic shock increases mortality. In a patient with cirrhosis and SBP, a third-generation cephalosporin (ceftriaxone) is standard first-line, but she has a severe penicillin anaphylaxis history and recent ceftriaxone exposure (resistance risk). Given anaphylaxis to penicillin, avoid cephalosporins with shared side chains and choose an alternative active against Enterobacterales - e.g., piperacillin-tazobactam is contraindicated by anaphylaxis, so use meropenem or ertapenem (cross-reactivity with penicillin is low for carbapenems but still requires caution and allergy input) or a non-beta-lactam such as ciprofloxacin plus metronidazole or aztreonam (no shared side chain with penicillin) with coverage tailored to local resistance. The decision must be made with allergy history in hand and documented.

Simultaneously: 30 mL/kg crystalloid (or albumin - albumin 1.5 g/kg day 1, 1 g/kg day 3 is recommended in SBP with renal impairment/high bilirubin to reduce renal failure), norepinephrine for MAP <65, and secondary peritonitis workup (CT, surgical consult) because low glucose/high LDH raise that concern.

2. How would you use the culture data and biomarkers over the next 48–72 hours to de-escalate, and what stewardship pitfalls must you avoid in cirrhosis?

Read the worked answer

De-escalation strategy:

  • Day 0–2: empiric broad coverage as above; repeat paracentesis at 48 hours to confirm falling PMN (should fall ≥25%); if not improving, reconsider secondary peritonitis, resistant organism, or another source.
  • When cultures return: narrow to the identified organism and susceptibility. If no growth (culture-negative SBP is common), de-escalate to the narrowest agent active against Enterobacterales based on local antibiogram and clinical response.
  • Duration: typically 5–7 days for uncomplicated SBP, longer if bacteremia or secondary peritonitis.
  • Biomarkers: trend lactate (should clear), WBC, and clinical status - do not use procalcitonin alone to stop antibiotics in cirrhosis; it is elevated by inflammation and liver dysfunction and is unreliable.

Stewardship pitfalls in cirrhosis:

  • Do not under-treat - SBP is life-threatening; the temptation to hold antibiotics pending cultures is a fatal error.
  • Avoid nephrotoxins (aminoglycosides, NSAIDs) and dose-adjust renally; monitor for hepatotoxicity (e.g., high-dose cefepime neurotoxicity, fluoroquinolone QT).
  • Do not extend antibiotics indefinitely for 'persistent ascites' without evidence - this drives resistance and C. difficile.
  • Secondary peritonitis must be excluded (low glucose/high LDH/protein) - antibiotics alone will fail if there is a perforation.
  • SBP prophylaxis (e.g., norfloxacin/ciprofloxacin) after an episode reduces recurrence, but must be balanced against resistance.
  • Document the allergy and rationale for any non-standard choice; involve allergy/pharmacy to clarify the anaphylaxis history and choose the safest effective agent.